Browsing by Author "Vasquez, M."
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- ItemAdaptación a la realidad de Latinoamérica de la Guía Clínica NASPGHAN/ESPGHAN 2016 sobre Diagnóstico, Prevención y Tratamiento de Infección por Helicobacter pylori en Pediatría(2020) Harris D., Paul R.; Calderon-Guerrero, O. G.; Vera Chamorro, J. F.; Lucero, Y.; Vasquez, M.; Ogata, S. K.; Angulo, D.; Madrazo, A.; Gonzales, J.; Gana Ansaldo, Juan Cristóbal; Rivero, A.
- ItemEffect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals(2015) Benavides, F.; Grossman, N.; Poggi, Helena; Nieto, E.; Bertran, A.; Araos, D.; Vasquez, M.; Ibarra, I.; Caceres, F.; Lagos Lucero, Sonia Marcela; Espinoza, K.; Repetto, G.
- ItemIdentification of Azadinium poporum (Dinophyceae) in the Southeast Pacific: morphology, molecular phylogeny, and azaspiracid profile characterization(2017) Tillmann, U.; Trefault Carrillo, Nicole Natalie; Krock, B.; Parada, G.; De la Iglesia Cabezas, Rodrigo Alonso; Vasquez, M.
- ItemOptimization of 2D-PAGE protocols for proteomic analysis of two nonaxenic toxin-producing freshwater cyanobacteria: Cylindrospermopsis raciborskii and Raphidiopsis sp.(2009) Plominsky, A. M.; Soto-Liebe, K.; Vasquez, M.Aims:
- ItemPrevalence and determinants of misreporting of energy intake among Latin American populations: results from ELANS study(2019) Previdelli, A. N.; Gómez, G.; Kovalskys, I.; Fisberg, M.; Cortés, L. Y.; Parej, R. G.; Liria, M. R.; García, M. C. Y.; Herrera Cuenca, M.; Rigotti Rivera, Attilio; Guajardo, V.; Zimberg, I. Z.; Murillo, A. G.; Fisberg, M.; Kovalskys, I.; Salas, G. G.; Sanabria, L. Y. C.; García, M. C. Y.; Torres, R. G. P.; Koletzko, B.; Moreno, L. A.; Pratt, M.; Guajardo, V.; Zimberg, I. Z.; Amigo, M. P.; Janezic, X.; Cardini, F.; Echeverry, M.; Langsman, M.; Fisberg, M.; Zimberg, I. Z.; De Franca, N. A. G.; Echeverría, G.; Landaeta, L.; Castillo Valenzuela, Oscar; Vargas, L. N.; Tobar, L. F.; Castillo, Y. M.; Rojas, R. M.; Chinnock, A.; Cáceres, M. V.; Torres, R. P.; Liria, M. R.; Meza, K.; Abad, M.; Penny, M.; Vasquez, M.; Rivas, O.; Meza, C.; Ruiz, S.; Ramírez, G.; Hernández, P.; Goncalves, P. B.; Alberico, C.; Ferrari, G. L. D. M.
- ItemTrombofilia primaria: detección y manifestación clínica en 105 casos(SOC MEDICA SANTIAGO, 2004) Srur, E.; Vargas, C.; Salas, S.; Parra, J.A.; Bianchi, V.; Mezzano, D.; Munoz, B.; Vasquez, M.; Pacheco, E.Background: Thrombophilia is defined as an altered hemostasis that predisposes to thrombosis. It can be primary when there is a family clustering of the disease or secondary, when it is associated to an acquired risk factor. Aim: to report clinical features in a series of patients with primary thrombophilia. Material and methods: Review of clinical records of patients with thrombotic episodes that lead to the suspicios of primary thrombophilia. Analysis of asymptomatic adult close relatives of these patients. Results: We repot 93 subjects (56 females, age range 14-77 years) with repeated episodes of thrombosis and a family history of thrombosis. Twenty four percent had protein C deficiency, 24% had antithrombin III deficiency, 18% had resistance to activated C protein by factor V Leiden, 10% had protein S deficiency, and 10% had the G20210 mutation of prothrombin gene. Among acquired defects studied simultaneously, 30% had lupus anticoagulent and 11% had hyperhomocysteinemia. Twenty four percent of cases had more than one thrombophilic risk factor. Among asymptomatic relatives, five had factor V Leiden, four had protein C deficiency and three had the G20210 mutation of prothrombin gene. Conclusions: Thrombophilia must be suspected in young subjects with thrombotic episode and a family history. the type of coagulation defect will determine prognosis, and the type of treatment (Rev Med Chile 2004; 132: 1466-73).